Hemoglobin vesicles containing methemoglobin and L-tyrosine to suppress methemoglobin formation in vitro and in vivo

Bioconjugate Chemistry

Volumn 17, Issue 5, 2006, Pages 1241-1245

  Atoji, Tomoyasu ^a   Aihara, Motonari ^a   Sakai, Hiromi ^a   Tsuchida, Eishun ^a   Takeoka, Shinji ^a  

^a WASEDA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; PHOSPHOLIPIDS;

2-GENERATED; CELLULARS; HAEMOGLOBINS; HEMOGLOBIN VESICLES; IN-VITRO; IN-VIVO; LIVING BODIES; PHOSPHOLIPID BILAYER MEMBRANES; REACTIVE OXYGEN SPECIES; VITRO AND IN VIVO;

HEMOGLOBIN;

DRUG CARRIER; HEMOGLOBIN; HEMOGLOBIN BASED OXYGEN CARRIER; HEMOGLOBIN DERIVATIVE; HYDROGEN PEROXIDE; METHEMOGLOBIN; OXYGEN; PEROXIDASE; REACTIVE OXYGEN METABOLITE; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTICLE; AUTOOXIDATION; CLEARANCE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ELECTRON; ENCAPSULATION; ENZYME ACTIVITY; HEMOGLOBIN SYNTHESIS; HEMOGLOBIN VESICLE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MEMBRANE VESICLE; NONHUMAN; OXYGEN AFFINITY; OXYGEN TRANSPORT; PHOSPHOLIPID BILAYER; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN SYNTHESIS INHIBITION; RAT;

EID: 33749021377     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc050349h     Document Type: Article

References (38)

1. Tsuchida, E. (1995) Artificial Red Cells, John Wiley and Sons, New York.
2. Winslow, R. M. (1997) Progress on blood substitutes. Nat. Med. 3, 474-474.
3. Chang, T. M. S. (1997) Blood Substitutes: Principles, Methods, Products and Clinical Trials, S. Karger AG, Switzerland.
4. Tsuchida, E., Ed. (1998) Blood Substitutes: present and future perspectives, Elsevier Science, Amsterdam.
5. Reiss, J. G. (2001) Oxygen carriers ("blood substitutes")- raison d'etre, chemistry, and some physiology. Chem. Rev. 101, 2797-2920.
6. D'Agnillo, F., and Alayash, A. I. (2001) Redox cycling of diaspirin cross-liked hemoglobin induced G2/M arrest and apoptosis in cultured endothelial cells. Blood 98, 3315-3323.
7. Przybelski, R. J., Dairy, E. K., and Birnbaum, M. L. (1997) The pressor of effect of hemoglobin - good or bad? In Advances in Blood Substitutes: Industrial Opportunities and Medical Challenges (Winslow, R. M., Vandegriff, K. D., and Intaglietta, M., Eds.) Birkhauser, Boston.
8. Gould, S. A., Moore, E. E., Hoyt, D. B., Burch, J. M., Haenel, J. B., Garcia, J., DeWoskin, R., and Moss, G. S. (1998) The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergency surgery. J. Am. Coll. Surg. 187, 113-122.
9. McCarthy, M. R., Vandegriff, K. D., and Winslow, R. M. (2001) The role of facilitated diffusion in oxygen transport by cell-free hemoglobins: implications for the design of hemoglobin-based oxygen carriers. Biophys. Chem. 92, 103-117.
10. Mullon, J., Giacoppe, G., Clagett, C., McCune, D., and Dillard, T. (2000) Transfusions of polymerized bovine hemoglobin in a patient with severe sutoimmune hemolytic anemia. N. Engl. J. Med. 342, 1638-1643.
11. Sloan, E. P., Koenigsberg, M., Gens, D., Cipolle, M., Runge, J., Mallory, M. N., and Rodman, G., Jr. (1999) Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy. JAMA 282, 1857-1864.
12. Sakai, H., Horinouchi, H., Tomiyama, K., Ikeda, E., Takeoka, S., Kobayashi, K., and Tsuchida, E. (2001) Hemoglobin-vesicles as oxygen carriers. Influence on phagocytic activity and histopathological changes in reticuloendothelial system. Am. J. Pathol. 159, 1079-1088.
13. Rudolph, A. S., Sulpizio, A., Hieble, P., MacDonald, V., Chavez, M., and Feuerstein, G. (1997) Liposome encapsulating attenuates hemoglobin-induced vasoconstriction inrabbit arterial segment. J. Appl. Physiol. 82, 1826-1835.
14. 50 Hb vesicles in transiently occluded arterioles of the hamster window model. Am. J. Physiol. 288, H2897-H2903.
15. Cabrales, P., Sakai, H., Tsai, A. G., Takeoka, S., Tsuchida, E., and Intaglietta, M. (2005) Oxygen transport by low and normal oxygen affinity hemoglobin vesicles in extreme hemodilution. Am. J. Physiol. 288, H1885-H1892.
16. Sakai, H., Masada, Y., Horinouchi, H., Ikeda, E., Sou, K., Takeoka, S., Suematsu, M., Takaori, M., Kobayashi, K., and Tsuchida, E. (2004) Physiological capacity of the reticuloendothelial system for the degradation of hemoglobin vesicles (artificial oxygen carriers) after massive intravenous doses by daily repeated infusions for 14 days. J. Pharmacol. Exp. Ther. 311, 874-884.
17. Yoshizu, A., Izumi, Y., Park, S., Sakai, H., Takeoka, S., Horinouchi, H., Ikeda, E., Tsuchida, E., and Kobayashi, K. (2004) Hemorrhagic shock resuscitation with an artificial oxygen carrier, hemoglobin vesicle, maintains intestinal perfusion and suppresses the increase in plasma tumor necrosis factor-α. ASAIO J. 50, 458-463.
18. Sakai, H., Takeoka, S., Park, S. I., Kose, T., Hamada, K., Izumi, Y., Yoshizu, A., Nishide, H., Kobayashi, K., and Tsuchida, E. (1997) Surface modification of hemoglobin vesicles with poly(ethylene glycol) and effects on aggregation, viscosity, and blood flow during 90% exchange transfusion in anesthetized rats. Bioconjugate Chem. 8, 23-30.
19. 2 reaction and lipid peroxidation. Bioconjugate Chem. 13, 1302-1308.
20. Teramura, Y., Kanazawa, H., Sakai, H., Takeoka, S., and Tsuchida, E. (2003) Prolonged oxygen-carrying ability of hemoglobin vesicles by coencapsulation of catalase in vivo. Bioconjugate Chem. 14, 1171-1176.
21. Herold, S., and Rock, G. (2003) Reactions of deoxy-, oxy-, and methemoglobin with nitrogen monoxide. J. Biol. Chem. 278, 6623-6634.
22. Shikama, K. (1998) The molecular mechanism of autoxidation for myoglobin and hemoglobin: A venerable puzzle. Chem. Rev. 98, 1357-1373.
23. Shikama, K. (1984) A controversy on the mechanism of autoxidation of oxymyoglobin and oxyhemoglobin: oxidation, dissociation, or displacement? Biochem. J. 223, 279-280.
24. Tomoda, A., Yoneyama, T., and Tsuji, A. (1981) Changes in intermediate hemoglobins during autoxidation of hemoglobin. Biochem. J. 195, 485-492.
25. Naito, Y., Fukutomi, I., Masada, Y., Sakai, H., Takeoka, S., Tsuchida, E., Abe, H., Hirayama, J., Ikebuchi, K., and Ikeda, H. (2002) Virus removal from hemoglobin solution using Planova membrane. J. Artif. Organs 5, 141-145.
26. Nagababu, E., and Rifkind, J. M. (2000) Reaction of hydrogen peroxide with ferrylhemoglobin: superoxide production and heme degradation. Biochemistry 39, 12503-12511.
27. Gunther, M. R., Sampath, V., and Caughey, W. S. (1999) Potential roles of myoglobin autoxidation in myocardial ischemia-reperfusion injury. Free Radical Biol. Med. 26, 1388-1395.
28. Svistunenko, D. A., Patel, R. P., Voloshchenko, S. V., and Wilson, M. T. (1997) The globin-based free radical of ferryl hemoglobin is detected in normal human blood. J. Biol. Chem. 272, 7114-7121.
29. 2 and p-hydroxyphenylacetic acid (HPA) in the fluorescence enzyme immunoassay. Z. Med. Laboratoriumsdiagn. 25, 14-21.
30. Yusa, K., and Shikama, K. (1987) Oxidation of oxymyoglobin to metmyoglobin with hydrogen peroxide: involvement of ferryl intermediate. Biochemistry 26, 6684-6688.
31. Fukuoka, T., Tachibana, Y., Tonami, H., Uyama, H., and Kobayashi, S. (2002) Enzymatic polymerization of tyrosine derivatives. peroxidase- and protease-catalyzed synthesis of poly(tyrosine)s with different structures. Biomacromolecules 3, 768-774.
32. Malencik, D. A., Sprouse, J. F., Swanson, C. A., and Anderson, S. R. (1996) Dityrosine: preparation, isolation, and analysis. Anal. Biochem. 242, 202-213.
33. Hinsberg, W. D., Milby, K. H., and Zare, R. N. (1981) Determination of insulin in serum by enzyme immunoassay with fluorimetric detection. Anal. Chem. 53, 1509-1512.
34. Sakai, H., Onuma, H., Umeyama, M., Takeoka, S., and Tsuchida, E. (2000) Photoreduction of methemoglobin by irradiation in the near-ultraviolet region. Biochemistry 39, 14595-14602.
35. Van Assendelft, O. W. (1970) Spectrophotometer of hemoglobin derivatives, Royal Vangorcum Ltd., Assen, The Netherlands.
36. Sakai, H., Hamada, K., Takaoka, S., Nishide, H., and Tsuchida, E. (1996) Physical properties of hemoglobin vesicles as red cell substitutes. Biotechnol. Prog. 12, 119-125.
37. 0 and two cross-linked derivatives with hydrogen peroxide: differential behavior of the ferryl intermediate. Arch. Biochem. Biophys. 316, 461-469.
38. Takeoka, S., Sakai, H., Kose, T., Mano, Y., Seino, Y., Nishide, H., and Tsuchida, E. (1997) Methemoglobin formation in hemoglobin vesicles and reduction by encapsulated thiols. Bioconjugate Chem. 8, 539-544.